Canine Hip Dysplasia: Reviewing the Evidence for Nonsurgical Management
Seattle Veterinary Specialists, Kirkland, WA.Veterinary Surgery (Impact Factor: 1.04). 12/2011; 41(1). DOI: 10.1111/j.1532-950X.2011.00928.x
OBJECTIVE: To systematically review the evidence available for nonsurgical management of hip dysplasia (HD). STUDY DESIGN: Literature review. METHODS: Databases (Pubmed, Veterinary Information Network) were searched for clinical studies on nonsurgical management of HD in dogs. The evidence in each study was reviewed and assigned a score (I-IV) based on previously reported levels of evidence. RESULTS: Fourteen articles were identified that met the inclusion criteria, including 3 Level IV, 4 Level III, and 7 Level II studies. Methods of nonsurgical management reviewed included: activity restrictions, weight management, acupuncture, modulation of joint disease by polysulfated glycosaminoglycans, mesenchymal stem cell therapy, and extra corporeal shock wave therapy. CONCLUSION: Weight management is an effective and important component of managing dogs with HD and associated osteoarthritis. Techniques that modulate the progression of joint disease may also be beneficial for treating dogs with HD. Further studies are needed to investigate other methods of managing HD such as hydrotherapy and physical rehabilitation.
Full-text previewDOI: · Available from: svsvet.com
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.
[Show abstract] [Hide abstract]
- "Mesenchymal stem cell (MSC) therapy is a newly developing therapeutic approach in OA that has proven useful in cartilage repair in a variety of animal models (Murphy et al., 2003; Black et al., 2007, 2008; Chong et al., 2007; Koga et al., 2008; Khan et al., 2010; Mokbel et al., 2011a, 2011b; Guercio et al., 2012; Jorgensen and Noel, 2012; Kirkby and Lewis, 2012). Bone marrow-derived MSCs hold particular promise for tissue repair because of their ability to engraft into tissues and differentiate into the target tissue cell type, including fibroblasts, osteocytes, adipocytes, chondrocytes and myocytes (Pittenger et al., 1999; Chamberlain et al., 2007). "
ABSTRACT: Current research indicates that exogenous stem cells may accelerate reparative processes in joint disease. However, no previous studies have evaluated whether bone marrow cells (BMCs) target the injured cranial cruciate ligament (CCL) in dogs. The objective of this study was to investigate engraftment of BMCs following intra-articular injection in dogs with spontaneous CCL injury. Autologous PKH26-labeled BMCs were injected into the stifle joint of eight client-owned dogs with CCL rupture. The effects of PKH26 staining on cell viability and PKH26 fluorescence intensity were analyzed in vitro using a MTT assay and flow cytometry. Labelled BMCs in injured CCL tissue were identified using fluorescence microscopy of biopsies harvested 3 and 13 days after intra-articular BMC injection. The intensity of PKH26 fluorescence declines with cell division but was still detectable after 16 days. Labelling with PKH26 had no detectable effect on cell viability or proliferation. Only rare PKH26-positive cells were present in biopsies of the injured CCL in 3/7 dogs and in synovial fluid in 1/7 dogs. No differences in transforming growth factor-β1, and interleukin-6 before and after BMC treatment were found and no clinical complications were noted during a 1 year follow-up period. In conclusion, BMCs were shown to engraft to the injured CCL in dogs when injected into the articular cavity. Intra-articular application of PKH26-labeled cultured mesenchymal stem cells is likely to result in higher numbers of engrafted cells that can be tracked using this method in a clinical setting.
[Show abstract] [Hide abstract]
- "In this study, we propose the use of acupuncture points for stem cell therapy. The practice of acupuncture is very old in human medicine and is also a well-described veterinary procedure  , although some controversial opinions have been expressed . Acupuncture has been used to treat dogs and cats for around 10 years, mainly for musculoskeletal problems , low back pain , knee osteoarthritis , tension-type headache, and migraine  . "
ABSTRACT: Stem cells isolated from adipose tissue show great therapeutic potential in veterinary medicine, but some points such as the use of fresh or cultured cells and route of administration need better knowledge. This study aimed to evaluate the effect of autologous stromal vascular fraction (SVF, n = 4 ) or allogeneic cultured adipose-derived stem cells (ASCs, n = 5 ) injected into acupuncture points in dogs with hip dysplasia and weak response to drug therapy. Canine ASCs have proliferation and differentiation potential similar to ASCs from other species. After the first week of treatment, clinical evaluation showed marked improvement compared with baseline results in all patients treated with autologous SVF and three of the dogs treated with allogeneic ASCs. On days 15 and 30, all dogs showed improvement in range of motion, lameness at trot, and pain on manipulation of the joints, except for one ASC-treated patient. Positive results were more clearly seen in the SVF-treated group. These results show that autologous SVF or allogeneic ASCs can be safely used in acupoint injection for treating hip dysplasia in dogs and represent an important therapeutic alternative for this type of pathology. Further studies are necessary to assess a possible advantage of SVF cells in treating joint diseases.
- [Show abstract] [Hide abstract]
ABSTRACT: Orthopedic conditions of the pelvic limb are some of the most frequently diagnosed causes of lameness in the dog. In the sporting dog as well as the active companion, acute stretch-induced muscle disorders are common occurrences, and are often under-, or misdiagnosed. This chapter reviews the anatomy, diagnosis, and treatment of iliopsoas and gracilis muscle strains. It then addresses the primary arthropathies of the pelvic limb including hip dysplasia (HD), hip luxation, and conditions of the stifle including cranial cruciate disease, meniscal injury, and patellar luxation. For these conditions, both medical and surgical management are discussed. The chapter concludes with descriptions and treatment options for common tendon injuries of the pelvic limb including calcanean tendon injury and luxation of the superficial digital flexor (SDF) tendon. Rehabilitation therapy for these tendon disorders is also discussed.